Proprio, a leading global company in AI-powered surgical technology, has welcomed Adam Spice to its Board of Directors. Adam currently serves as Chief Financial Officer at Rocket Lab, a prominent aerospace company specializing in launch services and space systems. He brings extensive financial expertise and a proven track record of helping fast-growing technology companies scale and expand internationally.
Health Technology Insights: Abbott’s Navitor TAVI Gets CE Mark for Expanded Use to Treat More People With Aortic Stenosis
Gabriel Jones, CEO of Proprio, praised Adam’s leadership and deep understanding of technically advanced industries. He noted that Adam’s strategic mindset and drive align perfectly with Proprio’s mission to revolutionize surgery and raise the standard for operating rooms worldwide.
Adam’s background in managing rapid growth and complex organizations in aerospace will be invaluable as Proprio expands its AI surgical platform across global markets. At Rocket Lab, he played a key role in driving a 78 percent increase in revenue year-over-year. His appointment comes at a critical time following Proprio’s recent FDA approval of its first AI-guided surgical system.
Health Technology Insights: NBA Star Amar’e Stoudemire Joins NOVODX Advisory Board
Adam expressed excitement about joining Proprio and contributing to this important phase in the company’s growth. He believes in the transformative power of breakthrough technologies and looks forward to collaborating with Gabriel Jones and the team to enhance surgical outcomes with AI-driven insights.
Both Proprio and Rocket Lab share a commitment to pushing the limits of their industries by developing innovative, cost-effective technologies. Alan Cohen, a Proprio board member and General Partner at DCVC, highlighted Adam’s expertise in scaling complex tech and achieving operational success as key reasons for his board appointment. Adam joins a distinguished group of leaders helping Proprio advance its goal of improving healthcare through AI-enabled surgical technology as the company broadens its platform across specialties and global markets.
Health Technology Insights: Kelly M. O’Brien M.D., Offers Hybrid Choice Concierge Program
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
